Alcon Inc. Profile Avatar - Palmy Investing

Alcon Inc.

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intra…
Medical - Instruments & Supplies
CH, Geneva [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 0% Bad
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 20.90 65.75 54.38
Graham Fair Price -23.50 21.83 28.54
PEG 412.19 -0.91 0.18
Price/Book 4.06 1.94 1.87
Price/Cash Flow -41.92 204.55 352.20
Prices/Earnings 80.99 40.83 22.56
Price/Sales 5.95 16.47 15.55
Price/FCF -41.92 204.55 352.20
Naive Interpretation member
01 - Valuation · Bad
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 2.95 0.56 0.55
Operating Margin -18.33 0.15 0.18
ROA -41.84 < 0.005 0.01
ROE 0.02 0.01 -42.51
ROIC 0.05 0.01 -76.84
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.01 < 0.005 52.96
Dividends QOQ -1.00 0.00 inf
EBIT QOQ 0.55 -0.19 -65.51
EPS QOQ 1.28 -0.45 -64.66
FCF QOQ -0.70 0.81 15.82
Revenue QOQ 0.06 < 0.005 -87.74
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 185.62 193.79 4.40
Days Sales Outstanding (DSO) 71.95 67.20 -6.60
Inventory Turnover 0.48 0.46 -4.21
Debt/Capitalization 0.19 0.20 3.78
Quick Ratio 1.24 1.31 5.66
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 41.80 42.18 0.90
Cash 2.23 2.32 4.09
Capex -0.75 -0.29 61.40
Free Cash Flow 0.22 0.40 80.77
Revenue 5.03 4.98 -0.91
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 2.28 2.51 10.31
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 5.17 5.84 12.83
Naive Interpretation Member
06 - Financial Health · Bad
End of ALC's Analysis
CIK: 1167379 CUSIP: H01301128 ISIN: CH0432492467 LEI: - UEI: -
Secondary Listings